scholarly journals Clinical Outcomes of Extracorporeal Shock Wave Therapy in Patients With Secondary Lymphedema: A Pilot Study

2013 ◽  
Vol 37 (2) ◽  
pp. 229 ◽  
Author(s):  
Hasuk Bae ◽  
Ho Jeong Kim
Keyword(s):  
Shock Wave ◽  
Pilot Study ◽  
Clinical Outcomes ◽  
Extracorporeal Shock Wave Therapy ◽  
Shock Wave Therapy ◽  
Secondary Lymphedema ◽  
Extracorporeal Shock Wave

scholarly journals The Effectiveness Of Radial Extracorporeal Shock Wave Therapy In Patients With Chronic Low Back Pain: A Prospective, Randomized, Single-Blinded Pilot Study

2019 ◽  
Vol Volume 14 ◽  
pp. 1859-1869 ◽  
Author(s):  
Karolina Walewicz ◽  
Jakub Taradaj ◽  
Katarzyna Rajfur ◽  
Kuba Ptaszkowski ◽  
Michał Tomasz Kuszewski ◽  
...  
Keyword(s):  
Shock Wave ◽  
Low Back Pain ◽  
Back Pain ◽  
Pilot Study ◽  
Chronic Low Back Pain ◽  
Extracorporeal Shock Wave Therapy ◽  
Low Back ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave

scholarly journals Extracorporeal shock wave therapy ameliorates secondary lymphedema by promoting lymphangiogenesis

2010 ◽  
Vol 52 (2) ◽  
pp. 429-434 ◽  
Author(s):  
Masayuki Kubo ◽  
Tao-Sheng Li ◽  
Takahiro Kamota ◽  
Mako Ohshima ◽  
Bungo Shirasawa ◽  
...  
Keyword(s):  
Shock Wave ◽  
Extracorporeal Shock Wave Therapy ◽  
Shock Wave Therapy ◽  
Secondary Lymphedema ◽  
Extracorporeal Shock Wave

Comparison Between Extracorporeal Shock Wave Therapy and Local Corticosteroid Injection for Plantar Fasciitis

2019 ◽  
Vol 41 (2) ◽  
pp. 200-205
Author(s):  
Dingli Xu ◽  
Weiyu Jiang ◽  
Dichao Huang ◽  
Xudong Hu ◽  
Yang Wang ◽  
...  
Keyword(s):  
Shock Wave ◽  
Clinical Outcomes ◽  
Clinical Improvement ◽  
Plantar Fasciitis ◽  
Corticosteroid Injection ◽  
Extracorporeal Shock Wave Therapy ◽  
Controlled Study ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave ◽  
Local Corticosteroid Injection

Background: Extracorporeal shock wave therapy (ESWT) is a nonsurgical treatment for plantar fasciitis (PF) that has had satisfactory clinical outcomes. However, local corticosteroid injection (LCI) is often regarded as first-line treatment of PF, but there have been few studies comparing the 2 methods. Therefore, we compared the effect of ESWT and LCI on patients with PF. Methods: This was a block randomized controlled study comparing 49 patients treated with ESWT and 47 patients treated with LCI from January 2017 to December 2018 who were followed for 6 months. We evaluated the clinical outcomes in the 2 groups, including average pain, first-step pain, plantar fascia thickness, and Foot Function Index, Chinese version of the PF patients. Results: All patients had pain relief and function improvement after treatment, whereas the LCI group did not maintain significant clinical improvement at the 3-month follow-up. The patients in the ESWT group had a significantly better clinical outcome with better duration of improvement than the LCI group. Conclusion: For PF patients, both ESWT and LCI resulted in clinical improvement but EWST provided longer relief than LCI. Level of Evidence: Level II, prospective comparative study.

scholarly journals Two methods of extracorporeal shock-wave therapy in a rat model of secondary lymphedema: a pilot study

2021 ◽  
Vol 49 (6) ◽  
pp. 030006052110244
Author(s):  
Hee Kyung Cho ◽  
Woo Jung Sung ◽  
Youn Ju Lee ◽  
Sang Gyu Kwak ◽  
Kang Lip Kim
Keyword(s):  
Shock Wave ◽  
Rat Model ◽  
Growth Factor Receptor ◽  
Extracorporeal Shock Wave Therapy ◽  
Control Group ◽  
Axillary Lymph ◽  
Sprague Dawley ◽  
Shock Wave Therapy ◽  
Secondary Lymphedema ◽  
Extracorporeal Shock Wave

Objectives To compare the effectiveness of two methods of extracorporeal shock-wave therapy (ESWT) in a rat model of forelimb lymphedema, induced by axillary lymph node dissection. Methods Sprague–Dawley rats were randomly allocated to a group that received 500 ESWT shocks only in the lymphedematous forelimb (Forelimb/ESWT) and a group that received 300 ESWT shocks in the axilla and 200 shocks in the lymphedematous forelimb (Axilla+Forelimb/ESWT). The circumferences of each limb were then measured. Immunohistochemistry for a pan-endothelial marker (cluster of differentiation [CD]31) and lymphatic vessel endothelial hyaluronan receptor-1, and western blot analysis for vascular endothelial growth factor receptor-3 (VEGFR3) and VEGF-C were performed. Results The circumferences of the limbs showed significant effects of group and time following surgery. The circumferences at the carpal joint and 2.5 cm above were smallest in the naïve limbs, larger in the Axilla+Forelimb/ESWT group, and the largest in the control group. VEGFR3 tended to be expressed at a higher level in the Axilla+Forelimb/ESWT group (1.96-fold) than in the Forelimb/ESWT group (1.20-fold) versus the opposite non-edematous forelimbs, although this difference was not statistically significant. Conclusions These data suggest that ESWT protocols have differential effects on angiogenesis and lymphangiogenesis in lymphedematous limbs.

scholarly journals Extracorporeal Shock Wave Therapy for Digital Ulcers of Systemic Sclerosis: A Phase 2 Pilot Study

2016 ◽  
Vol 238 (1) ◽  
pp. 39-47 ◽  
Author(s):  
Shinichiro Saito ◽  
Tomonori Ishii ◽  
Yukiko Kamogawa ◽  
Ryu Watanabe ◽  
Tsuyoshi Shirai ◽  
...  
Keyword(s):  
Shock Wave ◽  
Systemic Sclerosis ◽  
Pilot Study ◽  
Extracorporeal Shock Wave Therapy ◽  
Digital Ulcers ◽  
Phase 2 ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave

scholarly journals Clinical and Radiological Outcomes of Extracorporeal Shock Wave Therapy in Early-Stage Femoral Head Osteonecrosis

2018 ◽  
Vol 2018 ◽  
pp. 1-6 ◽  
Author(s):  
Abdulrahman D. Algarni ◽  
Hassan M. Al Moallem
Keyword(s):  
Shock Wave ◽  
Femoral Head ◽  
Clinical Outcomes ◽  
Treatment Option ◽  
Early Stage ◽  
Extracorporeal Shock Wave Therapy ◽  
Harris Hip Score ◽  
Shock Wave Therapy ◽  
Extracorporeal Shock Wave ◽  
Femoral Head Osteonecrosis

Objective. Femoral head osteonecrosis is a progressive clinical condition with significant morbidity and long-term disability. Several treatment modalities including both surgical and nonsurgical options have been used with variable levels of success. High-energy extracorporeal shock wave therapy is a nonoperative treatment option that has been described for early-stage disease. We aimed to assess the functional and radiological outcomes of extracorporeal shockwave therapy (ESWT) in the treatment of osteonecrosis of the femoral head (ONFH). Methods. Thirty-three hips of 21 patients were included in this study. Adult patients with ONFH of any etiology and in the precollapse stage were included. Clinical (visual analogue scale [VAS] and Harris hip score [HHS]) and radiological (plain radiographs and magnetic resonance imaging [MRI]) evaluations were performed before and after intervention. We used 3000–4500 pulses in a single session performed under general anesthesia. Results. At an average of 8 months after ESWT, pain scores and HHS were significantly improved compared with the preintervention scores (p<0.001). The overall clinical outcomes were improved in 21 hips (63.3%), unchanged in 5 hips (15.15%), and worsened in 7 hips (21.2%). A trend toward a decrease in the size of the ONFH was observed although not of clinical significance (p=0.235). MRI revealed significant resolution of bone marrow edema (p<0.003). Regression was observed in 9 lesions (42.9%) and progression in 1 lesion (4.7%); no change was observed in the remaining 23 lesions (52.4%). Conclusion. ESWT is a viable noninvasive treatment option for early-stage ONFH. It significantly improves clinical outcomes and may halt or delay the radiographic progression of the disease in the precollapse stage.

Sign in / Sign up

Export Citation Format

Share Document